Skip to content

Net margin at other companies

Opko Health logo
Opko HealthOPK
-36.6%-44.8pp
AMP
Amphastar PharmaceuticalsAMPH
11%-8.4pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
101.6%+60.1pp
Theravance Biopharma logo
Theravance BiopharmaTBPH
104.3%+71.4pp
HRO
HarrowHROW
-19.8%+18.0pp
Precigen logo
PrecigenPGEN
-3,656%

Other financials

Income statement

See full
Revenue$58.3M+104%
Gross profit$46.3M+86.8%
Operating income-$15.5M+80.4%
Net income-$30.4M+67.8%
EPS (diluted)-$0.37+71.8%

Balance sheet

See full
Cash & equivalents$180.9M-14.8%
Total debt$166.3M-18.3%
Total equity-$337.0M+0.4%
Total assets$305.1M+3.7%

Cash flow

See full
Operating cash flow-$15.6M+81.6%
CapEx$61.0K+239%
Free cash flow-$15.7M+81.5%

Valuation

See full
Market cap$846.21M+16.3%
Enterprise value$831.61M+15.7%
P/S4.1×-4.8×

Profitability

See full
Gross margin84.9%-1.3pp
Operating margin-47.1%-21.9pp
FCF margin-47.7%-22.1pp

Returns & leverage

See full
Return on equity-147.9%
Debt / equity5.6×
Current ratio2.2×-1.4×

Where this comes from

Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phathom Pharmaceuticals, Inc.'s net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phathom Pharmaceuticals, Inc.'s net margin?
Phathom Pharmaceuticals, Inc. (PHAT) reported net margin of -76.8% in Q1 2026.
How has Phathom Pharmaceuticals, Inc.'s net margin changed year-over-year?
Phathom Pharmaceuticals, Inc.'s net margin increased by 81.8% year-over-year, from -422.4% to -76.8%.
What is the long-term trend for Phathom Pharmaceuticals, Inc.'s net margin?
Over 2 years (2023 to 2025), Phathom Pharmaceuticals, Inc.'s net margin has grown at a -93.5% compound annual growth rate (CAGR), from -29,558.9% to -126.3%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.